How can today’s CDMOs ensure they can meet tomorrow's demands?

2 0

0 0

Exclusive Interview with Riccardo Braglia, Chairman of HAS Healthcare Advanced Synthesis SA

Insights on Strategic Growth & Innovation

In this latest interview, Riccardo Braglia, Chairman of HAS Group, shares valuable insights into the company's latest developments, strategic motivations, and future plans. We discuss the impactful acquisition of Cerbios-Pharma SA, technological advancements, capacity expansions, sustainability initiatives, and the role of 65 Equity Partners.

Don’t miss this comprehensive update on HAS Group’s vision and future trajectory.

1 0

It was a pleasure talking to Zara and learning more about innovation, technologies, digitalization, AI, and much more! Watch this insightful interview to discover more about Lonza.

1 0

1 0

Join us for an engaging interview with Carrie Mason, Head od the PAT Centre of Excellence at Lonza, where she discusses the latest trends shaping the analytics industry. Topics include the evolution of PAT tools, the importance of sustainability in analytics practices, and the transformative role of AI.

5 0

It was great to chat with Any Fenny, CCO at SK Pharmteco. We’ll talk about the new directions the company is heading, recent expansions, and some of the exciting investments they’ve been making. It’s a great chance to hear directly from Andy about what’s next for SK Pharmteco and how they’re evolving in the industry.

2 0

Peter Bains, MD & CEO of Syngene International, joins 24/7 Biopharma to discuss the company’s global CRDMO model, growing clinical trial capabilities in India, and its U.S. expansion through the Bayview facility in Baltimore. He highlights Syngene’s end-to-end R&D support for both small and large molecules, its 6,000-strong scientific team, and its work with 75% of the top 25 pharma companies. Bains also highlights SynVent, Syngene’s integrated discovery engine, as a key driver of early-stage biotech partnerships and future growth.

2 0